# Stryker

> Stryker builds medical technology for hospitals, surgery centers and emergency care teams, spanning joint implants, Mako surgical robotics, surgical equipment, neurovascular devices and clinical communications. Founded by orthopaedic surgeon Homer Stryker in 1941, the publicly traded company reported $25.116 billion in 2025 net sales.

- **Founded:** 1941
- **Headquarters:** Portage, United States
- **Founders:** Homer H. Stryker (Founder and orthopaedic surgeon)
- **Products:** Mako SmartRobotics, Joint replacement implants, Surgical equipment and visualization, Medical and emergency care equipment, Neurovascular and peripheral vascular devices
- **Notable:** Reported 2025 net sales of $25.116 billion, up 11.2% from 2024., Approximately 56,000 employees at December 31, 2025., Initial public offering in 1979.

## Products & services

- **Mako SmartRobotics** — Surgeon-controlled robotic assistance combining planning, guidance and haptic technology for supported orthopaedic procedures; acquired through MAKO in 2013.
- **Joint replacement implants** — Hip and knee reconstruction products, including the Triathlon knee family.
- **Surgical equipment and visualization** — Powered instruments, endoscopy, operating room integration and surgical navigation systems.
- **Medical and emergency care equipment** — Hospital beds, stretchers, patient handling equipment and emergency care devices.
- **Neurovascular and peripheral vascular devices** — Devices for stroke intervention and, through Inari, catheter-based mechanical thrombectomy for venous disease.
- **Vocera clinical communications** — Clinical communication and care coordination software and devices; acquisition announced in January 2022.
- **Sonopet 3** — Ultrasonic bone and soft tissue removal system with FDA 510(k) clearance announced October 14, 2026; full commercial launch anticipated later that fall.

## Achievements

- Reported 2025 net sales of $25.116 billion, up 11.2% from 2024.
- Approximately 56,000 employees at December 31, 2025.
- Initial public offering in 1979.
- Completed acquisition of Inari Medical on February 19, 2025.

## Latest updates

- **2026-10** — October 14: FDA 510(k) clearance announced for Sonopet 3; first clinical cases expected in October and full commercial launch anticipated later in fall.
- **2026-10** — October 12: announced CMR Surgical strategic alliance and approximately $400 million preferred equity investment, subject to closing conditions.
- **2026-10** — October 6: announced Spencer Stiles will succeed Kevin Lobo as CEO on January 1, 2027; Lobo will become Executive Chair.
- **2026-01** — January 29: reported full-year 2025 results, including $25.116 billion net sales.

## Links

- Website: https://www.stryker.com
- LinkedIn: https://www.linkedin.com/company/stryker
- Twitter/X: https://twitter.com/strykercomm
- YouTube: https://www.youtube.com/user/stryker
- Instagram: https://www.instagram.com/strykercareers/
- Facebook: https://www.facebook.com/strykercareers/

---

Profile page: https://yespress.io/stryker
Published by YesPress — https://yespress.io
Last updated: 2026-10-22